AKTX Logo

Akari Therapeutics, Plc (AKTX) 

NASDAQ$1.3+0.2 (18.18%)
Market Cap
$6,679.00
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
436 of 924
Rank in Industry
257 of 527

AKTX Insider Trading Activity

AKTX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$00–
Sells
$00–

Related Transactions

No records found

About Akari Therapeutics, Plc

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.

Insider Activity of Akari Therapeutics, Plc

Over the last 12 months, insiders at Akari Therapeutics, Plc have bought $0 and sold $0 worth of Akari Therapeutics, Plc stock.

On average, over the past 5 years, insiders at Akari Therapeutics, Plc have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,055,600 shares for transaction amount of $200,036 was made by Cohen Mark S (director) on 2015‑09‑18.

List of Insider Buy and Sell Transactions, Akari Therapeutics, Plc

2015-09-18PurchaseCohen Mark Sdirector
1.06M
0.0711%
$0.19$200,036-56.76%
2014-04-15PurchaseSABBY MANAGEMENT, LLC10 percent owner
17,100
0.3007%
$5.00$85,500+9.59%
2014-04-14PurchaseSABBY MANAGEMENT, LLC10 percent owner
3,000
0.0539%
$5.21$15,630+7.49%
2014-04-11PurchaseSABBY MANAGEMENT, LLC10 percent owner
100
0.0017%
$5.15$515+3.71%
2014-04-10PurchaseSABBY MANAGEMENT, LLC10 percent owner
1,400
0.0252%
$5.25$7,350+6.67%
2014-04-09PurchaseSABBY MANAGEMENT, LLC10 percent owner
1,075
0.0194%
$5.51$5,923+1.82%
2014-04-08PurchaseSABBY MANAGEMENT, LLC10 percent owner
35,500
0.6218%
$5.36$190,280+1.82%
2014-04-07PurchaseSABBY MANAGEMENT, LLC10 percent owner
20,654
0.3716%
$5.71$117,840-1.75%
2014-04-04PurchaseSABBY MANAGEMENT, LLC10 percent owner
12,250
0.216%
$6.07$74,400-9.44%
2014-04-02PurchaseSABBY MANAGEMENT, LLC10 percent owner
2,500
0.0441%
$6.15$15,375-10.49%
2014-04-01PurchaseSABBY MANAGEMENT, LLC10 percent owner
15,371
0.2742%
$6.10$93,806-8.58%
2014-03-31PurchaseSABBY MANAGEMENT, LLC10 percent owner
7,936
0.1396%
$6.35$50,394-13.25%
2014-03-27PurchaseSABBY MANAGEMENT, LLC10 percent owner
1,700
0.0344%
$6.61$11,237-14.55%
2014-03-26PurchaseSABBY MANAGEMENT, LLC10 percent owner
14,200
0.2876%
$6.66$94,619-15.17%
2014-03-25PurchaseSABBY MANAGEMENT, LLC10 percent owner
303
0.0061%
$6.90$2,091-18.78%
2014-03-24PurchaseSABBY MANAGEMENT, LLC10 percent owner
2,400
0.0465%
$6.71$16,104-19.29%
2014-03-21PurchaseSABBY MANAGEMENT, LLC10 percent owner
4,900
0.1002%
$6.83$33,467-16.30%
2014-03-20PurchaseSABBY MANAGEMENT, LLC10 percent owner
3,800
0.0768%
$6.90$26,220-18.12%
2014-03-17PurchaseSABBY MANAGEMENT, LLC10 percent owner
2,400
0.0479%
$6.65$15,960-16.14%
Total: 19

AKTX Institutional Investors: Active Positions

Increased Positions6+54.55%174,724+96.36%
Decreased Positions2-18.18%33,262-18.34%
New Positions5New169,328New
Sold Out Positions<1Sold Out33,260Sold Out
Total Postitions15+36.36%322,783+78.02%

AKTX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Palo Alto Investors Lp$158.000%146,024+146,024New2024-12-31
Omnia Family Wealth, Llc$95.000%87,62800%2024-12-31
Cerity Partners Llc$26.000%23,64300%2024-12-31
Renaissance Technologies Llc$25.000%23,465+5,396+29.86%2024-12-31
Cresset Asset Management, Llc$20.000%18,40800%2024-12-31
Catalina Capital Group, Llc$14.000%13,105+13,105New2024-12-31
Accent Capital Management, Llc$11.000%10,000+10,000New2024-12-31
Ubs Group Ag$00%194+194New2024-12-31
Bank Of America Corp /De/$00%15000%2024-12-31
Osaic Holdings, Inc.$00%10000%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1.67Strong BuyBuyHoldSellStrong SellAKTXHighAverageLowSeries 4